Venkatesh Srinivasan's most recent trade in Sutro Biopharma Inc was a trade of 2,500 Restricted Stock Unit (RSU) done . Disclosure was reported to the exchange on May 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 2,500 | 5,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 2,500 | 54,580 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.07 per share. | 01 May 2025 | 894 | 53,686 (0%) | 0% | 1.1 | 957 | Common Stock |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2025 | 21,250 | 21,250 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2025 | 21,250 | 59,683 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.60 per share. | 11 Apr 2025 | 7,603 | 52,080 (0%) | 0% | 0.6 | 4,562 | Common Stock |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 101,500 | 101,500 | - | - | Stock Option (Right to Buy) | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 94,250 | 94,250 | - | - | Restricted Stock Units (RSUs) | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 6,375 | 19,125 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 6,375 | 43,105 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 5,000 | 10,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 5,000 | 36,730 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.59 per share. | 01 Mar 2025 | 4,672 | 38,433 (0%) | 0% | 1.6 | 7,428 | Common Stock |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 2,500 | 7,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 2,500 | 32,622 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.74 per share. | 01 May 2024 | 892 | 31,730 (0%) | 0% | 3.7 | 3,336 | Common Stock |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 21,250 | 42,500 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 21,250 | 37,704 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. | 11 Apr 2024 | 7,582 | 30,122 (0%) | 0% | 4.5 | 34,119 | Common Stock |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 34,000 | 34,000 | - | - | Stock Option (Right to Buy Common Stock) | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 25,500 | 25,500 | - | - | Restricted Stock Units (RSUs) | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 5,000 | 18,503 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 5,000 | 15,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | CHIEF TECH OP OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.95 per share. | 01 Mar 2024 | 2,049 | 16,454 (0%) | 0% | 5.0 | 10,143 | Common Stock |
| Sutro Biopharma Inc | Venkatesh Srinivasan | Chief Tech Op Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 10,000 | 10,000 | - | - | Restricted Stock Unit (RSU) | |
| Sutro Biopharma Inc | Venkatesh Srinivasan | Chief Tech Op Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 7,500 | 7,500 | - | - | Stock Option (right to buy Common Stock) |